Prevalence, Patterns and Predictors of Psychotropic Polypharmacy Among Elderly Individuals with Parkinson's Disease In Long Term Care Settings In The United States

被引：7

作者：

Bhattacharjee, Sandipan ^{[1
]}

Goldstone, Lisa ^{[1
]}

Warholak, Terri ^{[1
]}

机构：

[1] Univ Arizona, Coll Pharm, Dept Pharm Practice & Sci, Tucson, AZ 85721 USA

来源：

JOURNAL OF PARKINSONS DISEASE | 2016年 / 6卷 / 01期

关键词：

Parkinson's disease; nursing homes; home health Care; psychotropic drugs; elderly; NURSING-HOME RESIDENTS; PSYCHOSIS; DEMENTIA; MEDICATIONS; DEPRESSION; ANTIPSYCHOTICS; DISORDERS; MORTALITY; PEOPLE; ADULTS;

D O I：

10.3233/JPD-150646

中图分类号：

Q189 [神经科学];

学科分类号：

071006 ;

摘要：

Background: Elderly individuals with Parkinson's disease (PD) generally suffer from more than one psychiatric comorbidity, which necessitates the use of concurrent psychotropic medications. To the best of the author's knowledge there are no nationally representative estimates of psychotropic polypharmacy among elderly individuals with PD in the United States (US). Objective: Therefore, the primary objective of this study was to examine the prevalence, patterns and predictors of psychotropic polypharmacy among elderly individuals with PD in the (US). Methods: Aretrospective, cross-sectional study design with 2004 National Nursing Home Survey (NNHS) and 2007 National Home and Hospice Care Survey (NHHCS) data was used. The analytic sample included elderly (age >= 65 years) individuals with PD. Antidepressants, antipsychotics, sedative/hypnotics, and anti-anxiety medications constituted the psychotropic medication classes. Concurrent use of two or more psychotropic medications was classified as psychotropic polypharmacy. Results: Approximately 93,648 and 37,439 elderly individuals with PD resided in nursing homes and home health settings respectively. Among elderly nursing home residents with PD, the nationally representative prevalence of psychotropic polypharmacy was 26.28%, whereas, it was 21.36% in the home health setting. Use of antidepressant medications constituted the majority of the psychotropic medication use among both nursing home (48.91%) and home health (40.98%) residents with PD. Multiple logistic regression analyses revealed that specific comorbidities were significantly associated with psychotropic polypharmacy among elderly nursing home residents with PD. Conclusions: These findings underscore the importance of evidence-based prescribing when psychotropic medications are used in elderly individuals with PD to reduce unnecessary polypharmacy.

引用

页码：247 / 255

页数：9

共 32 条

[21]

National Nursing Home Survey, 2004, DAT DOC

[22] The scientific and clinical basis for the treatment of Parkinson disease (2009) [J].

Olanow, C. Warren ;

Stern, Matthew B. ;

Sethi, Kapil .

NEUROLOGY, 2009, 72 (21) :S1-S136

[23] Prevalence of Anxiety Disorders and Anxiety Subtypes in Patients with Parkinson's Disease [J].

Pontone, Gregory M. ;

Williams, James R. ;

Anderson, Karen E. ;

Chase, Gary ;

Goldstein, Susanne A. ;

Grill, Stephen ;

Hirsch, Elaina S. ;

Lehmann, Susan ;

Little, John T. ;

Margolis, Russell L. ;

Rabins, Peter V. ;

Weiss, Howard D. ;

Marsh, Laura .

MOVEMENT DISORDERS, 2009, 24 (09) :1333-1338

[24] Effect of Citalopram on Agitation in Alzheimer Disease The CitAD Randomized Clinical Trial [J].

Porsteinsson, Anton P. ;

Drye, Lea T. ;

Pollock, Bruce G. ;

Devanand, D. P. ;

Frangakis, Constantine ;

Ismail, Zahinoor ;

Marano, Christopher ;

Meinert, Curtis L. ;

Mintzer, Jacobo E. ;

Munro, Cynthia A. ;

Pelton, Gregory ;

Rabins, Peter V. ;

Rosenberg, Paul B. ;

Schneider, Lon S. ;

Shade, David M. ;

Weintraub, Daniel ;

Yesavage, Jerome ;

Lyketsos, Constantine G. .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2014, 311 (07) :682-691

[25] A systematic review of prevalence studies of depression in Parkinson's disease [J].

Reijnders, Jennifer S. A. M. ;

Ehrt, Uwe ;

Weber, Wim E. J. ;

Aarsland, Dag ;

Leentjens, Albert F. G. .

MOVEMENT DISORDERS, 2008, 23 (02) :183-189

[26] Polypharmacy including falls risk-increasing medications and subsequent falls in community-dwelling middle-aged and older adults [J].

Richardson, Kathryn ;

Bennett, Kathleen ;

Kenny, Rose Anne .

AGE AND AGEING, 2015, 44 (01) :90-96

[27] Trigger medications and patient-related risk factors for Parkinson disease psychosis requiring anti-psychotic drugs: a retrospective cohort study [J].

Sawada, Hideyuki ;

Oeda, Tomoko ;

Yamamoto, Kenji ;

Umemura, Atsushi ;

Tomita, Satoshi ;

Hayashi, Ryutaro ;

Kohsaka, Masayuki ;

Kawamura, Takashi .

BMC NEUROLOGY, 2013, 13

[28] Identifying and distinguishing cases of parkinsonism and Parkinson's disease using ICD-9 CM codes and pharmacy data [J].

Swarztrauber, K ;

Anau, J ;

Peters, D .

MOVEMENT DISORDERS, 2005, 20 (08) :964-970

[29] Patterns of disability, care needs, and quality of life of people with Parkinson's disease in a general population sample [J].

Terriff, D. L. ;

Williams, J. V. A. ;

Patten, S. B. ;

Lavorato, D. H. ;

Bulloch, A. G. M. .

PARKINSONISM & RELATED DISORDERS, 2012, 18 (07) :828-832

[30] Presentation and management of psychosis in Parkinson's disease and dementia with Lewy bodies [J].

Weintraub, Daniel ;

Hurtig, Howard I. .

AMERICAN JOURNAL OF PSYCHIATRY, 2007, 164 (10) :1491-1498

← 1 2 3 4 →